Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program

Blood Cells. 1994;20(2-3):587-96; discussion 596-600.

Abstract

The usefulness of placental/umbilical cord blood as a source of stem cells for marrow reconstitution of HLA-matched siblings has now been extended to the unrelated-donor setting. The need for HLA-matched donor tissue makes it essential to have available a frozen inventory of ready-to-use placental blood units. The New York Blood Center's Placental Blood Project, designed to evaluate the practical feasibility of unrelated placental blood transplantation, consists of four basic modules: collection of placental blood, maternal samples and donor data, accession and testing for genetic and infectious disease markers, freezing placental blood units, and data organization and retrieval. Additional modules include a computerized HLA matching algorithm and organization of data about patients requiring transplantation, which may be best taken up by organ-sharing organizations in the future. In this report, we describe the organization and discuss the methods and overall experience after collecting the first 1,000 units and supplying the tissue for the first two unrelated-donor placental blood transplants.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Blood / immunology
  • Blood / microbiology
  • Blood / virology
  • Blood Banks* / organization & administration
  • Blood Banks* / standards
  • Blood Cell Count
  • Blood Donors
  • Blood Preservation
  • Bone Marrow Diseases / therapy*
  • Communicable Disease Control
  • Confidentiality
  • Cryopreservation
  • Feasibility Studies
  • Female
  • Fetal Blood / cytology*
  • HLA Antigens / immunology
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility Testing
  • Humans
  • Infant, Newborn
  • Informed Consent
  • Medical Records
  • New York
  • Placenta / blood supply*
  • Pregnancy

Substances

  • HLA Antigens